Related Experiment Video

Updated: Jan 24, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Therapeutic innovations in breast cancer

Fanny Le Du1, Christophe Perrin1, Angélique Brunot1

  • 1Centre Eugène-Marquis, avenue Bataille Flandres-Dunkerque, 35000 Rennes, France.

Presse Medicale (Paris, France : 1983)
|June 2, 2019
PubMed

Insights

This research explores advanced treatments for metastatic breast cancer, including CDK 4/6 inhibitors for endocrine resistance, antibody-drug conjugates for HER2+ and triple-negative breast cancer (TNBC), and PARP inhibitors for BRCA-mutated cancers.

Area of Science:

  • Oncology
  • Medical Research
  • Pharmacology

Background:

  • Endocrine resistance is a significant challenge in ER+ HER2- metastatic breast cancer.
  • HER2+ and triple-negative breast cancer (TNBC) require novel therapeutic strategies.
  • Targeting DNA damage response pathways offers new avenues for treatment.

Purpose of the Study:

  • To review current and emerging strategies for managing endocrine resistance in metastatic breast cancer.
  • To discuss novel antibody-drug conjugates for HER2+ and TNBC.
  • To explore the role of PARP inhibitors and immunotherapies in specific breast cancer subtypes.

Main Methods:

  • Literature review of clinical trials and research studies.
  • Analysis of emerging therapeutic targets and drug classes.
  • Focus on resistance mechanisms and novel treatment approaches.

Main Results:

  • CDK 4/6 inhibitors show promise in overcoming endocrine resistance in ER+ HER2- metastatic breast cancer.
  • Antibody-drug conjugates are advancing treatment for HER2+ and TNBC.
  • PARP inhibitors demonstrate efficacy in BRCA-mutated breast cancer.
  • Immunotherapies are being investigated for first-line metastatic TNBC.

Conclusions:

  • A multi-faceted approach is needed to address diverse breast cancer subtypes and resistance mechanisms.
  • Targeted therapies, including CDK 4/6 inhibitors, ADCs, PARP inhibitors, and immunotherapies, are expanding treatment options.
  • Continued research is crucial for optimizing outcomes in metastatic breast cancer.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis08:11

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Published on: August 14, 2016

32.5K

Related Concept Videos

Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.0K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.8K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
934